Key result
The presence of contractile fibrotic myocardium in patients with previous myocardial infarction was independently associated with a lower risk of cardiac events (HR 0.48) compared to its absence.
Why the study?
The study aimed to assess the prognostic value of myocardial fibrotic tissue with preserved or restored contractile activity in patients with previous myocardial infarction.
Does the presence of contractile fibrotic tissue on CMR predict better outcomes in patients with previous myocardial infarction?
Observational (n=730)
Yes
Does the presence of contractile fibrotic tissue on CMR predict better outcomes in patients with previous myocardial infarction?
Hazard Ratio: 0.48 (95% CI 0.33–0.68)
Absolute Event Rate: 14% vs 24.6%
p-value: p=<0.001
In patients with previous myocardial infarction, the presence of fibrotic myocardium that retains contractile activity on CMR is an independent predictor of improved survival.
May refine post-MI risk stratification on CMR; leaves open whether contractile fibrosis should guide ICD decisions.
BACKGROUND: Cardiovascular magnetic resonance permits assessment of irreversible myocardial fibrosis and contractile function in patients with previous myocardial infarction. We aimed to assess the prognostic value of myocardial fibrotic tissue with preserved/restored contractile activity. METHODS: In 730 consecutive myocardial infarction patients (64 ± 11 years), we quantified left ventricular (LV) end-diastolic (EDV) and end-systolic (ESV) volumes, ejection fraction (EF), regional wall motion (WM) (1 normal, 2 hypokinetic, 3 akinetic, 4 dyskinetic), and WM score index (WMSI), and measured the transmural (1-50 and 51-100) and global extent of the infarct scar by late gadolinium enhancement (LGE). Contractile fibrotic (CT-F) segments were identified as those showing WM-1 and WM-2 with LGE ≤ or ≥ 50%. RESULTS: During follow-up (median 2.5, range 1-4.7 years), cardiac events (cardiac death or appropriate implantable defibrillator shocks) occurred in 123 patients (17%). At univariate analysis, age, LVEDV, LVESV, LVEF, WMSI, extent of LGE, segments with transmural extent > 50%, and CT-F segments were associated with cardiac events. At multivariate analysis, age > 65 years, LVEF < 30%, WMSI > 1.7, and dilated LVEDV independently predicted cardiac events, while CT-F tissue was the only independent predictor of better outcome. After adjustment for LVEF < 30% and LVEDV dilatation, the presence of CT-F tissue was associated with good prognosis. CONCLUSIONS: In addition to CMR imaging parameters associated with adverse outcome (severe LV dysfunction, poor WM, and dilated EDV), the presence of fibrotic myocardium showing contractile activity in patients with previous myocardial infarction yields a beneficial effect on patient survival.
No takes yet. Share an insight, caveat, or question.
Bella et al. (2021) conducted an observational in Previous myocardial infarction (n=730). Presence of contractile fibrotic (CT-F) tissue vs. Absence of CT-F tissue was evaluated on Cardiac events (cardiac death or appropriate implantable defibrillator shocks) (HR 0.48, 95% CI 0.33-0.68, p=<0.001). The presence of contractile fibrotic myocardium in patients with previous myocardial infarction was independently associated with a lower risk of cardiac events (HR 0.48) compared to its absence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: